Skip to main content

Table 1 Israel’s NITAG meetings for the years 2010–2019 – Recommendations accepted

From: The National Immunization Technical Advisory Group in Israel

Year Main issues discussed by NITAG Recommendations
2010 Rubella vaccination program evaluation No change in the program
Priorities in adding new vaccines to the routine vaccination program 1st priority: Influenza vaccination of young children < age 5 years.
Accepted 2011.
2nd: Tdap for women after delivery
2011 Meningococcal Vaccines (international travel) Preference for conjugated Meningococcal Vaccines
Pneumococcal vaccination policy for infants Continue the successful Pneumococcal vaccination program
Influenza vaccination policy Recommending universal Influenza vaccination policy (aimed at all population groups aged 6 months and above).
Information on vaccines safety to the public How to present information on vaccines safety to the public? Recommended: use international publications by WHO, CDC, ECDC etc.
Herpes Zoster vaccine Recommended for persons 65 years old and above 2012 - Added to the national health basket in 50% discount
HPV vaccines: 4 valent vs. 2 valent Preference for the 4 valent HPV vaccine.
Rota Virus vaccine Introduction of Rota Virus vaccine into the national routine immunization schedule, 2011
2012 Use of PCV10 or PCV13 Continue the PCV13 in the national childhood vaccination program
Measles elimination strategies Adopting the measles elimination committee recommendations for disease surveillance and for improving and sustaining the measles vaccination coverage
2013 Polio vaccination policy During the “silent” WPV1 event in Israel (isolation in sewage in southern Israel, mainly Arab Bedouin localities).
Supporting the vaccination campaigns
Adding 2 bOPV vaccine doses at ages 6, 18 months to the schedule.
Tdap vaccine for pregnant women Tdap vaccine recommendation accepted for women in the third trimester of pregnancy. Applied in 2015.
PCV 13 for use in adults Recommended for adults in defined high-risk groups, Applied in 2016
HPV vaccines – safety review HPV vaccines safety review established before introduction into the routine immunization program in schools: 2013 – HPV vaccine for females 8th school grade
2014 Polio elimination Adopting the polio elimination committee recommendations for continuation of the polio virus environmental sewage sampling program and preparing an outbreak preparedness plan.
Keeping the bOPV vaccine at 6 and 8 months in the routine schedule.
2015 HPV vaccination policy Recommendation for a 2-dose HPV vaccination schedule
2015- females and males in the 8th school grade
Rotavirus vaccination provision in neonatal units Continue previous recommendation not to vaccinate infants while hospitalized in neonatal intensive care units (prolonged stay).
Priorities of introduction of new vaccines Recommended: Meningococcal vaccines and Hepatitis A vaccines for high risk groups. Applied in 2016
Influenza vaccination policy Preference of LAIV use in children
2016 Vaccination of the elderly - PCV PCV not indicated to healthy persons 65+ years.
Vaccination of the elderly - Herpes Zoster vaccine Herpes Zoster vaccine inclusion recommended to the basket of services committee. Included 2017 with price reduction of 50%
Influenza vaccination policy Vaccination of children in elementary schools. Program introduced in 2016–2017.
Preference for 4 strains Influenza vaccines. (2019: 4 strains)
Pregnancy after MMR Ratification of the recommendation indicating no need for interval between MMR vaccination and pregnancy.
2017 Definition of immunity status against measles Requiring written proof of measles vaccination status (except travelers).
Validity of immunity based on ELISA antibodies tests
2018 MenB vaccination policy Vaccination of high risk groups (included in the health basket 2020)
Neonatal BCG vaccination policy in risk groups Continue vaccination of neonates whose parents come from countries of high TB endemicity
National measles outbreak -
Mandatory vaccinations
Mandatory vaccinations and providing proof of vaccination before school entry were not recommended. In hyperendemic areas, unvaccinated children were banned from affected schools and kindergartens.
National measles outbreak -
vaccination in schools
Prioritization of measles vaccine over HPV and influenza vaccines.
Applied 2018–2019
2019 Influenza vaccines 3 or 4 strains, adjuvanted vaccines. NITAG recommended 4 strains.
Prioritizing Vaccinations to the national health basket MMR vaccine for the adult population, Updating schools’ HPV vaccine program (9 valent replaced 4 valent), MenB vaccine for high risk groups.
Included in the health basket 2020